Literature DB >> 22270473

Hypercapnic acidosis transiently weakens hypoxic pulmonary vasoconstriction without affecting endogenous pulmonary nitric oxide production.

Manja C A Nilsson1, Filip Fredén, Anders Larsson, Peter Wiklund, Maria Bergquist, Kristina Hambraeus-Jonzon.   

Abstract

PURPOSE: Hypercapnic acidosis often occurs in critically ill patients and during protective mechanical ventilation; however, the effect of hypercapnic acidosis on endogenous nitric oxide (NO) production and hypoxic pulmonary vasoconstriction (HPV) presents conflicting results. The aim of this study is to test the hypothesis that hypercapnic acidosis augments HPV without changing endogenous NO production in both hyperoxic and hypoxic lung regions in pigs.
METHODS: Sixteen healthy anesthetized pigs were separately ventilated with hypoxic gas to the left lower lobe (LLL) and hyperoxic gas to the rest of the lung. Eight pigs received 10% carbon dioxide (CO(2)) inhalation to both lung regions (hypercapnia group), and eight pigs formed the control group. NO concentration in exhaled air (ENO), nitric oxide synthase (NOS) activity, cyclic guanosine monophosphate (cGMP) in lung tissue, and regional pulmonary blood flow were measured.
RESULTS: There were no differences between the groups for ENO, Ca(2+)-independent or Ca(2+)-dependent NOS activity, or cGMP in hypoxic or hyperoxic lung regions. Relative perfusion to LLL (Q (LLL)/Q (T)) was reduced similarly in both groups when LLL hypoxia was induced. During the first 90 min of hypercapnia, Q (LLL)/Q (T) increased from 6% (1%) [mean (standard deviation, SD)] to 9% (2%) (p < 0.01), and then decreased to the same level as the control group, where Q (LLL)/Q (T) remained unchanged. Cardiac output increased during hypercapnia (p < 0.01), resulting in increased oxygen delivery (p < 0.01), despite decreased PaO(2) (p < 0.01)(.)
CONCLUSIONS: Hypercapnic acidosis does not potentiate HPV, but rather transiently weakens HPV, and does not affect endogenous NO production in either hypoxic or hyperoxic lung regions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22270473     DOI: 10.1007/s00134-012-2482-7

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  39 in total

1.  Environmental pH regulates LPS-induced nitric oxide formation in murine macrophages.

Authors:  Chun-Jen Huang; Ikram U Haque; Paul N Slovin; R B Nielsen; Xiaoying Fang; Jeffrey W Skimming
Journal:  Nitric Oxide       Date:  2002-02       Impact factor: 4.427

2.  Hypoxic pulmonary vasoconstriction is enhanced by inhibition of the synthesis of an endothelium derived relaxing factor.

Authors:  S L Archer; J P Tolins; L Raij; E K Weir
Journal:  Biochem Biophys Res Commun       Date:  1989-11-15       Impact factor: 3.575

Review 3.  The effect of cardiac output on arterial blood oxygenation.

Authors:  F W Cheney; P S Colley
Journal:  Anesthesiology       Date:  1980-06       Impact factor: 7.892

4.  Prolonged hypercapnia-evoked cerebral hyperemia via K(+) channel- and prostaglandin E(2)-dependent endothelial nitric oxide synthase induction.

Authors:  T Najarian; A M Marrache; I Dumont; P Hardy; M H Beauchamp; X Hou; K Peri; F Gobeil; D R Varma; S Chemtob
Journal:  Circ Res       Date:  2000-12-08       Impact factor: 17.367

5.  Blunted hypoxic pulmonary vasoconstriction by increased lung vascular pressures.

Authors:  J L Benumof; E A Wahrenbrock
Journal:  J Appl Physiol       Date:  1975-05       Impact factor: 3.531

6.  Determinants of nitric oxide in exhaled gas in the isolated rabbit lung.

Authors:  R E Carlin; L Ferrario; J T Boyd; E M Camporesi; D J McGraw; T S Hakim
Journal:  Am J Respir Crit Care Med       Date:  1997-03       Impact factor: 21.405

7.  Carbon dioxide induced vasorelaxation in rat mesenteric small arteries precontracted with noradrenaline is endothelium dependent and mediated by nitric oxide.

Authors:  P Carr; J E Graves; L Poston
Journal:  Pflugers Arch       Date:  1993-05       Impact factor: 3.657

8.  Independent influence of blood flow rate and mixed venous PO2 on shunt fraction.

Authors:  J Sandoval; G R Long; C Skoog; L D Wood; L Oppenheimer
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1983-10

9.  Acute hypercapnia improves indices of tissue oxygenation more than dobutamine in septic shock.

Authors:  Zhen Wang; Fuhong Su; Alejandro Bruhn; Xin Yang; Jean-Louis Vincent
Journal:  Am J Respir Crit Care Med       Date:  2007-10-18       Impact factor: 21.405

10.  Hypoxia potentiates nitric oxide synthesis and transiently increases cytosolic calcium levels in pulmonary artery endothelial cells.

Authors:  V Hampl; D N Cornfield; N J Cowan; S L Archer
Journal:  Eur Respir J       Date:  1995-04       Impact factor: 16.671

View more
  3 in total

1.  The role of anion exchanger on pulmonary vascular response to sustained alveolar hypoxia in the isolated perfused rabbit lung.

Authors:  Farzaneh Ketabchi; Somayeh Mansoori; Seyed Mostafa Shid Moosavi
Journal:  Iran J Med Sci       Date:  2015-05

2.  Pulmonary Macrophages Attenuate Hypoxic Pulmonary Vasoconstriction via β3AR/iNOS Pathway in Rats Exposed to Chronic Intermittent Hypoxia.

Authors:  Hisashi Nagai; Ichiro Kuwahira; Daryl O Schwenke; Hirotsugu Tsuchimochi; Akina Nara; Sayoko Ogura; Takashi Sonobe; Tadakatsu Inagaki; Yutaka Fujii; Rutsuko Yamaguchi; Lisa Wingenfeld; Keiji Umetani; Tatsuo Shimosawa; Ken-Ichi Yoshida; Koichi Uemura; James T Pearson; Mikiyasu Shirai
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

3.  Year in review in Intensive Care Medicine 2012: I. Neurology and neurointensive care, epidemiology and nephrology, biomarkers and inflammation, nutrition, experimentals.

Authors:  Massimo Antonelli; Marc Bonten; Maurizio Cecconi; Jean Chastre; Giuseppe Citerio; Giorgio Conti; J Randall Curtis; Goran Hedenstierna; Michael Joannidis; Duncan Macrae; Salvatore M Maggiore; Jordi Mancebo; Alexandre Mebazaa; Jean-Charles Preiser; Patricia Rocco; Jean-François Timsit; Jan Wernerman; Haibo Zhang
Journal:  Intensive Care Med       Date:  2012-12-18       Impact factor: 17.440

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.